Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage.

Le Coz C, Bengsch B, Khanna C, Trofa M, Ohtani T, Nolan BE, Henrickson SE, Lambert MP, Kim TO, Despotovic JM, Feldman S, Fadugba OO, Takach P, Ruffner M, Jyonouchi S, Heimall J, Sullivan KE, Wherry EJ, Romberg N.

J Allergy Clin Immunol. 2019 Aug 22. pii: S0091-6749(19)31092-9. doi: 10.1016/j.jaci.2019.08.007. [Epub ahead of print]

PMID:
31445098
2.

Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children.

Kim TO, Despotovic JM.

Hematol Oncol Clin North Am. 2019 Jun;33(3):489-506. doi: 10.1016/j.hoc.2019.01.005. Epub 2019 Mar 23. Review.

PMID:
31030815
3.

Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.

Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, Lambert MP, Rothman JA, Breakey VR, Hege K, Bennett CM, Rose MJ, Haley KM, Buchanan GR, Geddis A, Lorenzana A, Jeng M, Pastore YD, Crary SE, Neier M, Neufeld EJ, Neu N, Forbes PW, Despotovic JM.

Am J Hematol. 2019 Jul;94(7):741-750. doi: 10.1002/ajh.25479. Epub 2019 Apr 29.

PMID:
30945320
4.

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.

Tarantino MD, Bussel JB, Blanchette VS, Beam D, Roy J, Despotovic J, Raj A, Carpenter N, Mehta B, Eisen M.

Haematologica. 2019 Nov;104(11):2283-2291. doi: 10.3324/haematol.2018.202283. Epub 2019 Mar 7.

5.

Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review.

Kim TO, Grimes AB, Kirk S, Arulselvan A, Lambert MP, Grace RF, Despotovic JM.

Am J Hematol. 2019 Apr;94(4):461-466. doi: 10.1002/ajh.25409. Epub 2019 Feb 4.

PMID:
30663792
6.

Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature.

Neunert CE, Despotovic JM.

Pediatr Blood Cancer. 2019 Apr;66(4):e27569. doi: 10.1002/pbc.27569. Epub 2018 Dec 10. Review.

PMID:
30537439
7.

Pediatric ITP: is it different from adult ITP?

Despotovic JM, Grimes AB.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):405-411. doi: 10.1182/asheducation-2018.1.405. Review.

PMID:
30504339
8.

Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment.

O'Brien SH, Despotovic JM, Neunert CE.

J Pediatr. 2019 Jan;204:11-13. doi: 10.1016/j.jpeds.2018.08.062. Epub 2018 Sep 28. No abstract available.

PMID:
30274924
9.

Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.

van Beers EJ, van Straaten S, Morton DH, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA, Sharma M, Neufeld EJ, Sheth S, Despotovic JM, Kollmar N, Pospíšilová D, Knoll CM, Kuo K, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Verhovsek M, Kunz J, McNaull MA, Rose MJ, Bradeen HA, Addonizio K, Li A, Al-Sayegh H, London WB, Grace RF.

Haematologica. 2019 Feb;104(2):e51-e53. doi: 10.3324/haematol.2018.196295. Epub 2018 Sep 13. No abstract available.

10.

PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome: A rare cause of childhood neutropenia associated with systemic inflammation and hyperzincemia.

Hashmi SK, Bergstrom K, Bertuch AA, Despotovic JM, Muscal E, Xia F, Bi W, Marcogliese A, Diaz R.

Pediatr Blood Cancer. 2019 Jan;66(1):e27439. doi: 10.1002/pbc.27439. Epub 2018 Sep 10.

PMID:
30198636
11.

IVIg and FcγRIIb in kids with ITP: individualizing therapy.

Despotovic JM, Bussel JB.

Blood. 2018 Aug 30;132(9):877-878. doi: 10.1182/blood-2018-07-861690. No abstract available.

PMID:
30166359
12.

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.

Grace RF, Despotovic JM, Bennett CM, Bussel JB, Neier M, Neunert C, Crary SE, Pastore YD, Klaassen RJ, Rothman JA, Hege K, Breakey VR, Rose MJ, Shimano KA, Buchanan GR, Geddis A, Haley KM, Lorenzana A, Thompson A, Jeng M, Neufeld EJ, Brown T, Forbes PW, Lambert MP.

Am J Hematol. 2018 Jul;93(7):882-888. doi: 10.1002/ajh.25110. Epub 2018 May 6.

13.

Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.

Grace RF, Bianchi P, van Beers EJ, Eber SW, Glader B, Yaish HM, Despotovic JM, Rothman JA, Sharma M, McNaull MM, Fermo E, Lezon-Geyda K, Morton DH, Neufeld EJ, Chonat S, Kollmar N, Knoll CM, Kuo K, Kwiatkowski JL, Pospíšilová D, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Kunz J, Sheth S, Rose MJ, Bradeen HA, Neu N, Guo D, Al-Sayegh H, London WB, Gallagher PG, Zanella A, Barcellini W.

Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.

PMID:
29549173
14.

Eltrombopag for use in children with immune thrombocytopenia.

Kim TO, Despotovic J, Lambert MP.

Blood Adv. 2018 Feb 27;2(4):454-461. doi: 10.1182/bloodadvances.2017010660. Review.

15.

Laboratory investigation of hydraulic characteristics of fly ash as a fill material from the aspects of pollutant transport.

Stanić F, Jaćimović N, Ranđelović A, Despotović J.

Water Sci Technol. 2017 Aug;76(3-4):976-982. doi: 10.2166/wst.2017.243.

PMID:
28799943
16.

Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders.

Bernhardt MB, De Guzman MM, Grimes A, Kirk S, Nelson S, Bergsbaken J, Minard CG, Despotovic JM.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26759. Epub 2017 Aug 9.

PMID:
28792663
17.

Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells.

Jevtić B, Djedović N, Stanisavljević S, Despotović J, Miljković D, Timotijević G.

J Agric Food Chem. 2016 Jun 22;64(24):4900-7. doi: 10.1021/acs.jafc.6b00951. Epub 2016 Jun 8.

PMID:
27225664
18.

Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study.

Neunert C, Despotovic J, Haley K, Lambert MP, Nottage K, Shimano K, Bennett C, Klaassen R, Stine K, Thompson A, Pastore Y, Brown T, Forbes PW, Grace RF; Pediatric ITP Consortium of North America (ICON).

Pediatr Blood Cancer. 2016 Aug;63(8):1407-13. doi: 10.1002/pbc.26003. Epub 2016 May 2.

19.

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.

Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M.

Lancet. 2016 Jul 2;388(10039):45-54. doi: 10.1016/S0140-6736(16)00279-8. Epub 2016 Apr 18.

PMID:
27103127
20.

Further insight into the mechanism of heavy metals partitioning in stormwater runoff.

Djukić A, Lekić B, Rajaković-Ognjanović V, Veljović D, Vulić T, Djolić M, Naunovic Z, Despotović J, Prodanović D.

J Environ Manage. 2016 Mar 1;168:104-10. doi: 10.1016/j.jenvman.2015.11.035. Epub 2015 Dec 14.

PMID:
26699454
21.

Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.

Bussel JB, de Miguel PG, Despotovic JM, Grainger JD, Sevilla J, Blanchette VS, Krishnamurti L, Connor P, David M, Boayue KB, Matthews DC, Lambert MP, Marcello LM, Iyengar M, Chan GW, Chagin KD, Theodore D, Bailey CK, Bakshi KK.

Lancet Haematol. 2015 Aug;2(8):e315-25. doi: 10.1016/S2352-3026(15)00114-3. Epub 2015 Jul 28. Erratum in: Lancet Haematol. 2015 Oct;2(10):e407.

PMID:
26688484
22.

Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with wiskott-Aldrich syndrome.

O'Connell AE, Volpi S, Dobbs K, Fiorini C, Tsitsikov E, de Boer H, Barlan IB, Despotovic JM, Espinosa-Rosales FJ, Hanson IC, Kanariou MG, Martínez-Beckerat R, Mayorga-Sirera A, Mejia-Carvajal C, Radwan N, Weiss AR, Pai SY, Lee YN, Notarangelo LD.

Front Immunol. 2014 Jul 18;5:340. doi: 10.3389/fimmu.2014.00340. eCollection 2014.

23.

Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?

Despotovic JM, Neunert CE.

Hematology Am Soc Hematol Educ Program. 2013;2013:283-5. doi: 10.1182/asheducation-2013.1.283. Review.

PMID:
24319192
24.

Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warning.

Thompson JC, Klima J, Despotovic JM, O'Brien SH.

Pediatr Blood Cancer. 2013 Nov;60(11):E149-51. doi: 10.1002/pbc.24633. Epub 2013 Jun 27.

PMID:
23813881
25.

RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia.

Despotovic JM, McGann PT, Smeltzer M, Aygun B, Ware RE.

Pediatr Blood Cancer. 2013 Sep;60(9):E106-8. doi: 10.1002/pbc.24574. Epub 2013 May 27.

PMID:
23712954
26.

The clinical and laboratory spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] disease.

Cook CM, Smeltzer MP, Mortier NA, Kirk SE, Despotovic JM, Ware RE, Hankins JS.

Hemoglobin. 2013;37(1):16-25. doi: 10.3109/03630269.2012.753547.

PMID:
23297836
27.

A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.

McGann PT, Despotovic JM, Howard TA, Ware RE.

Am J Hematol. 2012 Mar;87(3):266-71. doi: 10.1002/ajh.22254. Epub 2011 Nov 25.

28.

RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).

Despotovic JM, Lambert MP, Herman JH, Gernsheimer TB, McCrae KR, Tarantino MD, Bussel JB.

Transfusion. 2012 May;52(5):1126-36; quiz 1125. doi: 10.1111/j.1537-2995.2011.03384.x. Epub 2011 Oct 7. Review.

29.

Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia.

Ware RE, Despotovic JM, Mortier NA, Flanagan JM, He J, Smeltzer MP, Kimble AC, Aygun B, Wu S, Howard T, Sparreboom A.

Blood. 2011 Nov 3;118(18):4985-91. doi: 10.1182/blood-2011-07-364190. Epub 2011 Aug 29.

30.

Thrombopoiesis: new ITP paradigm?

Despotovic JM, Ware RE.

Blood. 2011 Jul 7;118(1):1-2. doi: 10.1182/blood-2011-05-351700. No abstract available.

PMID:
21737604
31.

'Predicting long-term PID sequelae with treatment markers' by Trautmann et al.

Madden T, Hladky K, Allsworth J, Houston L, Despotovic J, Schaecher C.

Am J Obstet Gynecol. 2008 Jan;198(1):143-4; discussion e11-4. doi: 10.1016/j.ajog.2007.11.063. Review. No abstract available.

PMID:
18166331
32.

Discussion: 'Spot urine testing in evaluation of preeclampsia' by Wheeler et al.

Odibo AO, Martin KA, Allsworth JE, Rampersad R, Despotovic J.

Am J Obstet Gynecol. 2007 May;196(5):e1-5; discussion 491-2. No abstract available.

PMID:
17466663
33.

Inefficiency of storm water inlets as a source of urban floods.

Despotovic J, Plavsic J, Stefanovic N, Pavlovic D.

Water Sci Technol. 2005;51(2):139-45.

PMID:
15790237
34.

Supplemental Content

Loading ...
Support Center